+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery.

The major challenges faced in securing these approvals include identifying clinical relevance in the context of therapeutic targets and novel technologies to measure disease activity, reproducibility, variability issues- and finally translation of discoveries to FDA approved clinical tests.

The 3rd Annual Biomarker Conference taking place on the 8th and 9th of February 2018, in San Diego-CAUSA, aims to gather experts from pharma, bio-pharma companies and research institutes to discuss current challenges and opportunities in therapeutic biomarkers, CDx, regulations, reimbursement models and disease specific applications of biomarkers.

Post Show Report 201
Click here to view post-show report of the 2nd Annual Biomarker Conference.

This event is co-located with our 3rd Annual Genome Editing & Engineering Conference and 3rd Annual NGS Data Analysis and Informatics Conference.


conference Registration Form



Academic Delegate$399
Industry Delegate $549
Solution Provider Delegate$1199
Industry Delegate (Early Bird) - 31st October 2017$440
Academic Delegate (Early Bird) - 31st October 2017$320


Key Highlights

  • Emerging therapeutic biomarkers
  • Exosomes
  • Tissue-based biomarker analysis
  • Immune-Oncology Biomarker Development
  • Next Generation Biomarker Translation
  • Biomarkers beyond companion diagnostics
  • Biomarkers for CNS disorders

 For more information on the agenda of the conference, you can write us at amit.shelke@marketsandmarkets.com

Who Should Attend ?

Researchers, scientists, clinicians, academicians and professionals from

  • Pharmaceutical companies
  • Bio-pharma companies
  • Research institutes

Working in:

  • Biomarker
  • Biomarker discovery
  • Biomarker development
  • Biomarker Sciences
  • Correlative sciences
  • Translational research
  • Biomarkers in Neurological disorders
  • Imaging Biomarkers
  • Companion Diagnostics

Why attend:

  • 30+ experts from academia and industry presenting their current work in Biomarkers
  • Latest updates on regulatory guidelines and approvals
  • Case studies from experts who have successfully created and developed a biomarker
  • Facilitated networking sessions to ensure quality interactions
  • One on one query handling by biomarker experts
  • Opportunity to develop long-lasting business relationships and networking opportunities with senior peers.


  • Diane Stephenson

    Executive Director, Critical Path Institute (C-Path), Tucson, Arizona
  • Shashi Ramaiah

    Executive Director, Global Head – Biomarkers, Pfizer, Cambridge, Massachusetts
  • Wolfgang Sadee

    Felts Mercer Professor of Medicine and Pharmacology, The Ohio State University, Columbus, Ohio
  • Ann Kapoun

    VP, Translational Medicine, OncoMed Pharmaceuticals Inc., San Francisco, California
  • Siwen Hu-Lieskovan

    Assistant Clinical Professor, UCLA, Los Angeles, California
  • Lynne T. Bemis

    Chair of Biomedical Sciences, Department of Biomedical Sciences, University of Minnesota Medical School, Duluth Campus, Duluth, Minnesota
  • Michael Gillette

    Instructor/Senior Research Fellow, Proteomics and Biomarker Discovery, Dana-Farber Cancer Institute/Broad Institute, Boston/Cambridge, Massachusetts
  • Nataly Manjarrez Orduño

    Translational scientist in autoimmunity and immuno-oncology, Bristol-Myers Squibb, Newyork
  • Raghu Kalluri

    chairman and professor,Department of Cancer Biology, Director, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas
  • George Vasmatzis

    co-director, biomarker discovery program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota
  • Katherine Call

    Senior Director & Head, Proteogenomics Translational Sciences, Sanofi, Framingham, Massachusetts,
  • Jeffrey Wallin

    Sr. Director, Biomarkers and Diagnostics, Seattle Genetics Inc, San Francisco
  • Anna Katrin Szardenings

    Director Biomarker Operations & Imaging, Janssen Research & Development, San Diego, CA
  • Janusz Dutkowski

    Founder and CEO, Data4Cure, Inc, San Diego
  • Jody D Berry

    Director of Research, Immunochemistry, Grifols, Emeryville
  • Raj Chavali

    Sr. Director, Caris Life Sciences, San Fransisco
  • Bob Terbrueggen

    CEO, DxTerity, Los Angeles
  • Jarret Glasscock

    Founder and CEO, Cofactor Genomics, San Francisco
  • Linda Jung

    Business Development, Olink Proteomics, Sweden/Massachusetts
  • Chih-Liang Chin

    Director and Head of Pacific Translational Biomarkers, Merck, South San Francisco, California
  • Janica Wong

    Senior Scientist, Merck, San Francisco
  • Steven Potts

    Vice President, Global Medical and Diagnostic Affairs, Ignyta, Arizona
  • Valentina Kouznetsova

    Associate Research Professor, The Moores Cancer Center, University of California, San Diego



Gold Sponsor


DxTerity is a patient-centric genomics company bringing the power of real-world genomics with From-Home RNA monitoring to improving the management of immune-mediated diseases. With patented and proprietary technologies that engage patients where they live, DxTerity is increasing clinical study efficiency while transforming the management of immune-mediated disease by helping to provide a more complete picture of an individual’s health. DxTerity also provides services and technologies to partner organizations including running population-scale genomic studies.


 Olink Proteomics

Swedish company Olink Proteomics provides innovative solutions for targeted human protein biomarker discovery, with rapid, high-throughput analysis, exceptional data quality and minimal sample consumption. Using our Proximity Extension Assay (PEA) technology, 1 µl of samples are analyzed for 92 biomarkers simultaneously, with exceptional readout specificity. Disease or biological process-focused panels are available, with full transparency on our rigorous validation data. Olink panels are available as ready-to-use kits or via our fee-for service offering. 

almac Almac Diagnostics

 Almac Diagnostics is a precision medicine company, focused on the discovery, development and commercialization of complex diagnostic tests. The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years.

Our diagnostic experience spans oncology, immunology, CNS, and infective diseases. We offer clients a highly Customized CDx partnership approach with tailored solutions, utilizing complex biology, to help you differentiate your drug in the marketplace.

MYRIAD RBM Myriad RBM, Inc. 

Myriad RBM, Inc. is a leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) technology. This platform provides researchers with reproducible and quantitative data for hundreds of proteins in a cost-effective manner.  All services are performed in our CLIA certified laboratory

ACDAdvanced Cell Diagnostics

Advanced Cell Diagnostics – a Bio-Techne Brand, is a world leader in RNA biomarker analysis for precision medicine, providing the most advanced RNA analysis solutions for cell and tissue based research, drug discovery/development and diagnostics in molecular pathology. Its proprietary award-winning RNAscope® technology is capable of detecting and quantifying RNA biomarkers with single-molecule sensitivity and single-cell resolution. This technology has been cited in over 1000 peer-reviewed publications by a rapidly growing user base.


Caris Life Sciences®

Caris Life Sciences®is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. Caris Molecular Intelligence®, the company’s Comprehensive Genomic Profiling Plus molecular testing service, assesses DNA, RNA and proteins to reveal a molecular blueprint to guide personalized treatment decisions. ADAPT Biotargeting System™, the company’s revolutionary and unbiased profiling platform, is being utilized for drug target identification, therapeutic discovery, companion diagnostics, cancer screening and biomarker identification.



DATA4CURE’s Biomedical Intelligence® Cloud combines systems biology with an advanced semantic AI integration engine to turn big omics and clinical data into a continuously updated biomedical knowledge graph. By actively mining thousands of public and proprietary datasets and millions of biomedical publications this technology discovers genes, pathways and networks underlying disease and treatment response, merging diverse pieces of evidence to increase statistical power and facilitating continuous translation of data to knowledge. Leading pharmaceutical companies use the platform every day to search for new targets, repurpose drugs for new indications, identify disease subtypes, and predict drug response and resistance in patients.

Aura Analytics

Aural Analytics

Any intervention for neurological damage or disease requires objective outcome measures to assess effectiveness. Aural Analytics delivers these measures based on analysis of patients' complex behaviors. We utilize decades of research which show that changes in complex behaviors correspond to changes in neurological health. This provides a powerful alternative to the current method: subjective evaluation by clinical experts. We provide outcome measures both for pharmaceutical company clinical trials and for clinicians working directly with patients.

Millipore SigmaMillipore SiGMa

As your research uncovers the significant role of more and more biomarkers in both normal and disease states, you need a reliable partner for quality assays and consistent performance. We not only offer you the largest portfolio of biomarker assays—including ELISAs, RIAs and MILLIPLEX® MAP-- our kits and reagents provide you with consistent, high-quality tools so that you can do your best work while saving time, labor and cost.



Cofactor is a biotechnology and software company using RNA as the foundation for providing a better understanding of disease. We’ve developed tools to quantify complex molecular profiles and provide comprehensive characterization of immune response. We offer translational and clinical assays, database development, and custom assay design with a CAP/CLIA-accredited RNA sequencing laboratory. Leading the industry in bringing RNA-based assays into the clinic, Cofactor is a trusted partner for immune-oncology and precision medicine. 

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

 For sponsorship opportunities please contact us at events@marketsandmarkets.com


All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Email: events@marketsandmarkets.com

Academic delegatesFree
Industry and Solution Provider delegates$99

Posters Submission Form




BioUtah is an independent, non-profit 501(c) (6) trade association serving Utah's life science industry. Our primary members include organizations focused on research and development, manufacturing and commercialization or provide supportive services to life science technologies and treatments.Utah’s life science industry consists of a diverse spectrum with strengths in medical device manufacturing and services, research and testing, biotechnology, pharmaceuticals and healthcare IT amongst others; and is a key driver of Utah’s economy.

 California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization.


Colorado BioScience Association

Colorado BioScience Association
 champions life science. The not-for-profit organization represents more than 350 member organizations and serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA grows the bioscience workforce and leads business expansion policies to advance the industry in our state.

 Georgia Bio

Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

To support 3rd Annual Biomarker Conference, please contact Amit at amit.shelke@marketsandmarkets.com


3rd Annual Biomarker Conference will be held at the Double Tree by Hilton San Diego Mission Valley in San Diego, CA 

Double Tree by Hilton San Diego Mission Valley
7450 Hazard Center Drive
San Diego, CA
92108For information on directions and transportation, please visit this link

Hotel Booking Link
Accommodation is currently available at the Double Tree by Hilton San Diego Mission Valley in discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not 
authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com.

About the Hotel

DoubleTree by Hilton Hotel San Diego - Mission Valley puts you in the center of San Diego. The adjacent trolley stop offers a ride to the city’s top attractions including SDCCU Stadium (formerly known as Qualcomm Stadium), San Diego Zoo, Old Town, Little Italy and Gaslamp Quarter. A pedestrian bridge links our hotel to Hazard Center’s eclectic mix of shops and restaurants and we are within walking distance to San Diego’s famed Fashion Valley Mall.

For further Information, please contact:
Email: events@marketsandmarkets.com